Dr Eddie Wang
Prosiectau fel Prif Ymchwiliwr
- Cellular and viral immunology resource (23.04.2006 - 22.01.2010)
- Characterisation of a novel class of natural killer cell immunoevasin (01.05.2021 - 28.02.2025)
- Commercial supply of DR3 Knock out (01.04.2015 - 29.02.2016)
- DR3 knockout (01.08.2012 - 31.07.2013)
- Exploring innate-like and adaptive gamma delta T cell paradigms in health and disease (01.03.2021 - 28.02.2026)
Prosiectau fel Cyd-Ymchwiliwr
- An analysis of wild type human cytomegalovirus (01.12.2010 - 08.05.2014)
- A systematic investigation into human cytomegalovirus gene function (08.05.2014 - 31.12.2017)
- Automated 384-capacity real-time quantitative polymerase chain reaction (qPCR) facility (01.08.2012 - 31.07.2013)
- Death receptor 3: A regulator of bone turnover and new target for therapy for osteoporosis? (01.10.2009 - 01.10.2012)
- Developing a novel anti-SARS-CoV-2 Immunotherapy (01.01.2024 - 31.08.2025)